Transense Technologies PLC
16 June 2000
Extracts from Chairman's statement at AGM June 16th 2000.
'This Year has been one of considerable progress for Transense. We have
successfully moved the listing of our shares from OFEX to AIM, made
considerable progress on a number of aspects of our technology including the
registration of patents and negotiated several important commercial
agreements.
Our strategy is not to manufacture anything apart from prototypes. It is then
up to the application and manufacturing licensees to finalise the buying and
selling between themselves. In some cases, Transense will receive an up front
royalty payment. This amount will depend on how much has been made available
to develop the application. I am pleased to say that in all cases Transense
will receive on-going royalties on sales.
This month, we signed an exclusive agreement with Sawtek of the USA whereby
they will make our Surface Acoustic Wave (SAW) devices for sale to our
application licensees. This transaction is a major benchmark in Transense's
history, signalling to the automotive industry that large companies support
our view that our technology is a world beater and that they are prepared to
fund the design and tooling costs that are necessary for large volume
manufacturing. Sawtek is one of the fastest growing SAW manufacturers in the
world, currently making around 150 million devices a year. It is quoted on
NASDAQ with a market valuation of some $2.5 billion.
We are close to a manufacturing licence agreement with Thomson-CSF, one of the
world's largest integrated circuit manufacturers, which will have closed the
loop on the first part of our journey. These two agreements will demonstrate
to potential buyers that products exploiting our technology can be
manufactured in the huge volumes necessary for the applications to which they
are naturally suited.
Our next challenge will be the application licensees who will buy components
from the manufacturers. You will recall that we have already signed a user
licence contract with SmarTire for tyre pressure monitoring. It is now our
aim to concentrate our efforts on not only expanding this market sector but
also the others applications that lend themselves to our technology. I am
pleased to say that discussions are taking place with a number of such
companies with this in view.
By licensing our technology we have efficiently saved ourselves millions of
pounds in costs that would have been incurred by trying to go it alone. This
way we not only achieve credibility for our technology we do it without the
inherent manufacturing risks and costs'.
Graham Jarrett, Chairman.
For further information, please contact:
James Perry
Chief Executive, Transense Technologies plc 01869 238 030
Graeme Bayley
Manager Growth Companies Team, HSBC 020 7336 9000
John Coyle
Clerkenwell Communications 020 7713 0900
0370 687 370
07699 727 796 (pager)
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.